NCT03080337

Brief Summary

This study aims to use an innovative and integrated educational curriculum to deliver prenatal care and diabetes care for pre-gestational diabetic women from approximately the first trimester of pregnancy through delivery and the early postpartum period in a group care model. The group care model will be compared to a control group, a traditional, individual care model.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable pregnancy

Timeline
Completed

Started Mar 2017

Shorter than P25 for not_applicable pregnancy

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 27, 2017

Completed
16 days until next milestone

First Posted

Study publicly available on registry

March 15, 2017

Completed
2 days until next milestone

Study Start

First participant enrolled

March 17, 2017

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 22, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 22, 2018

Completed
Last Updated

August 22, 2025

Status Verified

December 1, 2019

Enrollment Period

11 months

First QC Date

February 27, 2017

Last Update Submit

August 20, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Compliance with glucose testing over time

    Compare the glucose compliance of participants in the group care model to the control group: a traditional, individual care model.

    2 years

Secondary Outcomes (12)

  • Maternal Weight Gain (kilograms)

    2 years

  • Length of stay for delivery (days)

    2 years

  • Presence of infection (Y/N)

    2 years

  • Type of Delivery (Vaginal, C-Section, Vacuum, Forceps, other)

    2 years

  • Blood Pressure (mm Hg)

    2 years

  • +7 more secondary outcomes

Study Arms (2)

Traditional Care

NO INTERVENTION

If the participant is randomized to the individual prenatal care model, she will continue to receive individualized care in the prenatal clinic. This includes being seen by both a MFM specialist and possibly an endocrinologist at each prenatal visit. During the prenatal visit, the individual caregivers are responsible for discussing educational topics that they feel are relevant to the patient. Patients are seen every two weeks for Traditional Care.

Group Care

EXPERIMENTAL

If the participant is randomized into the group prenatal care model she will be placed in a group of approximately 6-10 women of approximately the same gestational age. These women will then have sessions scheduled at the same intervals they would have had their traditional prenatal visits, every two weeks until 36 weeks and then weekly until delivery, 12 sessions in total. Each session will last between 90-120 minutes. In the group prenatal care model, the entire visit time will be face to face with a provider and the group. Billing will be done through the standard reimbursement system since the program will follow the schedule of prenatal visits recommended by the American Congress of Obstetricians and Gynecologist.

Other: Group Care

Interventions

Participation in 12 group sessions with 6-10 women who are also pregnant and have diabetes.

Group Care

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Clinically confirmed viable pregnancy at the time of enrollment.
  • Able to provide consent for participation.
  • Diabetes diagnosed prior to 12 weeks gestation.
  • Initiation of care by 20 weeks gestation.
  • Age 18 years or older.

You may not qualify if:

  • Not planning to deliver at UnityPoint Health- Meriter Hospital.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UnityPoint Health- Meriter Hospital

Madison, Wisconsin, 53715, United States

Location

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Kara Hoppe, DO

    University of Wisconsin, Madison

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 27, 2017

First Posted

March 15, 2017

Study Start

March 17, 2017

Primary Completion

February 22, 2018

Study Completion

February 22, 2018

Last Updated

August 22, 2025

Record last verified: 2019-12

Data Sharing

IPD Sharing
Will share

Data will be shared in a REDCap database with University Hospitals, Cleveland.

Shared Documents
STUDY PROTOCOL, CSR
Time Frame
At time of study completion for up to 1 year.
Access Criteria
De-identified data variables will be shared as this will be a shared enrollment effort.

Locations